NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / September 4, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of BrightSpring Health Services, Inc. ("BrightSpring Health Services, Inc.") (NASDAQ:BTSG) concerning possible violations of federal securities laws. BrightSpring conducted its initial public offering ("IPO") of 53,333,334 shares of common stock priced at $13.00 per share on or around January 25, 2024.
BrightSpring Health Services stock has underperformed since its IPO. The company aims to address important pain points in healthcare, such as reducing costs and providing seamless patient experiences. Despite a potential double-digit upside, caution is advised due to erratic financial performance, high debt, and uncertain growth projections.
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Pomerantz LLP is investigating claims on behalf of investors of BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Pomerantz LLP is investigating claims on behalf of investors of BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Pomerantz LLP is investigating claims on behalf of investors of BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK CITY, NY / ACCESSWIRE / August 21, 2024 / Pomerantz LLP is investigating claims on behalf of investors of BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BrightSpring Health Services, Inc. ("BrightSpring" or "the Company") (NASDAQ:BTSG). Investors who purchased BrightSpring securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BTSG.
NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BrightSpring Health Services, Inc. ("BrightSpring" or "the Company") (NASDAQ:BTSG). Investors who purchased BrightSpring securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BTSG.
NEW YORK, NY / ACCESSWIRE / August 19, 2024 / NEW YORK, August 19, 2024 (ACCESSWIRE) Pomerantz LLP is investigating claims on behalf of investors of BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
LOS ANGELES, CA / ACCESSWIRE / August 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of BrightSpring Health Services, Inc. ("BrightSpring" or "the Company") (NASDAQ:BTSG) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BrightSpring Health Services, Inc. ("BrightSpring" or "the Company") (NASDAQ:BTSG). Investors who purchased BrightSpring securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BTSG.